<DOC>
	<DOC>NCT00779844</DOC>
	<brief_summary>Pharmacokinetic models for anesthetic agents are questionable. The objective of the study is to compare the propofol and remifentanil doses required to maintain the bispectral index in the range 40-60 in two groups of patients: obese patients and lean patients</brief_summary>
	<brief_title>Anesthesic Propofol and Remifentanil Requirements in Obese Patients</brief_title>
	<detailed_description />
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>Patients scheduled for a bariatric coelioscopic surgical procedure (obese patients) or for an upper abdominal laparoscopic procedure (lean patients) age lower than 18 years, pregnant woman, presence of a central neurological disorder or a lesion cerebral, of a severe respiratory or hepatic insufficiency, allergy to propofol, or to soja or to peanuts, or to sufentanil, or to remifentanil, or to morphine, or to a muscle myorelaxant, or to an excipient, hypersensibility to sufentanil, or to remifentanil or to another derivate of fentanyl, allergy to latex, presence of a symptomatic gastroesophageal reflux, patients receiving a psychotropic treatment or a agonistantagonist opiate, presence of predictive signs of difficult mask ventilation of difficult intubation (else than obesity)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Anesthesia</keyword>
	<keyword>Obesity</keyword>
</DOC>